BPC-157 and GLP-1 medications operate through fundamentally different biological systems, which is why clinicians consider them compatible
doi: 10.1016/S0006-3495(96)79317-7 Heuer, KH, Mackay, JP, Podzebenko, P, Bains, NPS, Weiss, AS, King, GF and EasterbrookSmith, SB (1996)
After he published a series of animal and cell studies on humanins potential benefitsthe peptide seemed to curb inflammation, control glucose, and possibly even provide protection against Alzheimersso-called biohackers began ordering it on the gray market
While there are reports of forthcoming appointments, the committee does not presently appear to have a quorum, a procedural issue that could affect its ability to act at the scheduled meeting